ammed cancer guide book - chapter3

8/6/2019 AmMed Cancer Guide Book - Chapter3

1/58


2/58

3


3/58

3

142

3.1

1

2

3

4

5

6


4/58

143

6

5

4

3

2

1


5/58

144

1

2

3

4

5

6


6/58


7/58

146

1

2

3

4

5

6


8/58

3

147

6

5

4

3

2

1


9/58

148

1

2

3

4

5

6

(Minimally invasive surgical

procedure)(Cryosurgery)

(Laser surgery)

3.2


10/58

3

149

6

5

4

3

2

1

103

1

25

710


11/58

150

1

2

3

4

5

6

34


12/58

3

151

6

5

4

3

2

1


13/58

152

1

2

3

4

5

6

I.

II.

III.

Questionto Ask

???


14/58

3

153

6

5

4

3

2

1

IV.

V.

VI.

VII.

1895X

1898

X


15/58

154

1

2

3

4

5

6

1.

2.

3.

(

)

1015


16/58

3

155

6

5

4

3

2

1

2

3


17/58


18/58

3

157

6

5

4

3

2

1

I.

II.

III.

IV. V.

VI.

VII.

VIII.

Louis GoodmanAlfred Gilman

(nitrogen mustard)

Questionto Ask

???


19/58

158

1

2

3

4

5

6

(lymphoma)(leukemias)

(microscopic metastases)

(oncologists)

50

2-5


20/58

3

159

6

5

4

3

2

1

1)2)

3)

/

(Intravenous injection)


21/58

160

1

2

3

4

5

6

(Oral administration)

Xeloda

Capecitabine

Xeloda

Xeloda

TP55-FU

FYI


22/58


23/58


24/58

3

163

6

5

4

3

2

1

V.

VI.

VII.

VIII.

IX.


25/58

164

1

2

3

4

5

6

2-3


26/58

3

165

6

5

4

3

2

1

5

(CINV)


27/58

166

1

2

3

4

5

6

(CINV)

(CINV)

24(1-2)4-6

24


28/58

3

167

6

5

4

3

2

1

CINV

CINV

a.

CINV

CINV

CINV

CINV


29/58

168

1

2

3

4

5

6

b.

CINV

50CINV

CINV

CINV

CINV

(Antiemetics)


30/58

3

169

6

5

4

3

2

1


31/58

170

1

2

3

4

5

6

CINV


32/58

3

171

6

5

4

3

2

1


33/58


34/58

3

173

6

5

4

3

2

1


35/58

174

1

2

3

4

5

6

11


36/58

3

175

6

5

4

3

2

1

()


37/58

176

1

2

3

4

5

6

(3000ml)


38/58

3

177

6

5

4

3

2

1

3.3

Targeted Therapy

1990


39/58

178

1

2

3

4

5

6

:

1)

EGFRHerceptin

TrastuzumabErbitux

CetuximabB

CD20

MabTheraRituximab

2)

AVASTIN

3) Growth factor

receptor inhibitor


40/58

3

179

6

5

4

3

2

1

Glivec

IressaTarceva

Angiogenesis

AVASTIN Roche

bevacizumab

FYI


41/58

180

1

2

3

4

5

6

Avastin

Avastin


42/58

3

181

6

5

4

3

2

1

HER2

Trastuzumab

Lapatinib

American Society of Clinical Oncology

FYI


43/58

182

1

2

3

4

5

6

Hormonal Therapy

1.


44/58

3

183

6

5

4

3

2

1

2.

3.


45/58

184

1

2

3

4

5

6

Immunotherapy


46/58

3

185

6

5

4

3

2

1

2

BCG

a2


47/58

186

1

2

3

4

5

6

Stem cell transplant

Stem

cells


48/58

3

187

6

5

4

3

2

1

1.

2.

3.


49/58

188

1

2

3

4

5

6

Cancer Gene Therapy


50/58

3

189

6

5

4

3

2

1


51/58

190

1

2

3

4

5

6


52/58

3

191

6

5

4

3

2

1

3.4

Complementary and

alternative medicine

1.Alternative

?

2.Complementary


53/58

192

1

2

3

4

5

6

Herbal medicine


54/58

3

193

6

5

4

3

2

1

Diet

Alternative diet

Enzyme

(Acupuncture


55/58

194

1

2

3

4

5

6

Massage

3 0 0 0

Hippocrates460-377

scented bath

1.Aromatherapy

Cedar wood

Rosemary


56/58

3

195

6

5

4

3

2

1

2.Reflexology

3.Acupressure

Qigong


57/58

196

1

2

3

4

5

6

Yoga

Hypnotherapy


58/58

3

5

4

3

2

1

ammed cancer guide book - chapter3

Documents